Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers

Documenti analoghi

• Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers
  di: Escudero Javier, et al.
  Pubblicazione: (2011-12-01)
• Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
  di: Hu, William T., et al.
  Pubblicazione: (2010)
• Machine learning diagnosis of mild cognitive impairment using advanced diffusion MRI and CSF biomarkers
  di: Alexander Y. Guo, et al.
  Pubblicazione: (2025-07-01)
• Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
  di: Grambaite, Ramune, et al.
  Pubblicazione: (2013)
• CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
  di: Fjell, Anders M., et al.
  Pubblicazione: (2010)